牛雙芽巴貝西蟲(chóng)免疫熒光試劑盒

babesia bigemina IFA Kit

廣州健侖生物科技有限公司

主要用途：用于檢測(cè)牛血清中的牛雙芽巴貝西蟲(chóng)IgG/IgM抗體

產(chǎn)品規(guī)格：12 孔/張,10 張/盒

主要產(chǎn)品包括：包柔氏螺旋體菌、布魯氏菌、貝納特氏立克次體、土倫桿菌、鉤端螺旋體、新型立克次體、恙蟲(chóng)病、立克次體、果氏巴貝西蟲(chóng)、馬焦蟲(chóng)、牛焦蟲(chóng)、利什曼蟲(chóng)、新包蟲(chóng)、弓形蟲(chóng)、貓流感病毒、貓冠狀病毒、貓皰疹病毒、犬瘟病毒、犬細(xì)小病毒等病原微生物的 IFA、MIF、ELISA試劑。

牛雙芽巴貝西蟲(chóng)免疫熒光試劑盒

我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、西尼羅河、立克次體、無(wú)形體、蜱蟲(chóng)、恙蟲(chóng)、利什曼原蟲(chóng)、RK39、漢坦病毒、深林腦炎、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲(chóng)病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測(cè)、食品安全檢測(cè)等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

歡迎咨詢(xún)

歡迎咨詢(xún)2042552662

二維碼掃一掃

【公司名稱(chēng)】 廣州健侖生物科技有限公司
【】    楊永漢 
【】 
【騰訊 】 2042552662
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-3室
【企業(yè)文化】

秦燕研究組研究發(fā)現(xiàn)，在核糖體的翻譯因子結(jié)合部位存在一個(gè)脯氨酰開(kāi)關(guān)(Proline Switch)，它的構(gòu)象決定核糖體對(duì)翻譯因子的招募與否。深入研究發(fā)現(xiàn)，控制該開(kāi)關(guān)的酶就是翻譯因子。因此，核糖體與翻譯因子之間存在著對(duì)彼此的共調(diào)控。而這種調(diào)控關(guān)系，在所有的蛋白質(zhì)翻譯G蛋白(trGTPase)與核糖體之間存在，說(shuō)明其具有普遍意義：在翻譯的全部過(guò)程中，包括起始、延長(zhǎng)、終止和再循環(huán)，都由這個(gè)脯氨酰開(kāi)關(guān)調(diào)控招募翻譯G蛋白。
這項(xiàng)研究工作與同所的龔為民研究員、許瑞明研究員，以及德國(guó)馬普學(xué)會(huì)分子遺傳研究所K. H. Nierhaus教授合作完成，得到了國(guó)家科技部、國(guó)家基金委、中國(guó)科學(xué)院的資助。
2007年，美國(guó)國(guó)立衛(wèi)生研究院NIH宣布進(jìn)行為期兩年、總值340萬(wàn)美元的癌癥基因組圖譜研究計(jì)劃(Cancer Genome Atlas pilot program)，這一計(jì)劃目標(biāo)是“測(cè)試一種大規(guī)模、系統(tǒng)性分析癌細(xì)胞基因組變化的方法的可行性”，為檢測(cè)、治療、預(yù)防癌癥提供基因組信息。
在過(guò)去的幾年里，這一項(xiàng)目陸續(xù)獲得了一些研究成果，而在的這項(xiàng)研究中，由加州大學(xué)圣克魯茲分校Buck研究所Christopher Benz和 Christina Yau的研究組采用6種不同的TCGA“平臺(tái)技術(shù)(platform technologies)”，分析了12種不同腫瘤類(lèi)型樣品的DNA，RNA和蛋白，希望能從中發(fā)現(xiàn)不同類(lèi)型的腫瘤如何相互區(qū)分。
Cell:相同癌癥起源的細(xì)胞具有更多分子和遺傳上的相似性
研究結(jié)果表明相對(duì)于癌癥起源的組織類(lèi)型，如乳房腎臟、膀胱等，相同癌癥起源的細(xì)胞類(lèi)型具有更多分子和遺傳上的相似性。

Qin Yan research group found that ribosome translation factor binding site there is a prolyl switch (Proline Switch), its conformation determines ribosomes on the translation factor recruitment or not. In-depth study found that the enzyme that controls the switch is a translation factor. Therefore, there is a mutual regulation between ribosomes and translation factors. This regulatory relationship, which exists between all the trGTPases and ribosomes, is of universal significance: the entire process of translation, including initiation, elongation, termination, and recycling, is controlled by this Prolyl switch regulation recruits translated G proteins.
This work was done in collaboration with Prof. Gong Weimin, Prof. Xu Ruiming, and Prof. K. H. Nierhaus, Institute of Molecular Genetics, Maple Institute, with the support of the State Ministry of Science and Technology, the State Commission of Science and the Chinese Academy of Sciences.
In 2007, the National Institutes of Health NIH announced a two-year, $ 3.4 million, Cancer Genome Atlas pilot program that aims to "test a large-scale, systematic analysis of cancer Feasibility of Approaches to Cell Genome Changes "to provide genomic information for the detection, treatment and prevention of cancer.
In the past few years, the project has received some research results, and in the latest study, the research team led by Christopher Benz and Christina Yau of the Buck Institute at the University of California, Santa Cruz, used six different TCGA "Platform technologies," analyzes DNA, RNA, and proteins in 12 different tumor types in hopes of discovering how different types of tumors distinguish each other.
Cell: Cells of the same cancer have more molecular and genetic similarities
The results suggest that there are more molecular and genetic similarities in the cell types of the same cancer origin relative to the type of tissue from which the cancer originated, such as breast kidney, bladder, and the like.